CMPUY logo

CompuGroup Medical SE & Co. KGaA (CMPUY)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

CMPUY steht fuer CompuGroup Medical SE & Co. KGaA, ein Healthcare-Unternehmen mit einem Kurs von $ (Marktkapitalisierung 0). Bewertet mit 48/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 16. März 2026
48/100 KI-Bewertung

CompuGroup Medical SE & Co. KGaA (CMPUY) Gesundheitswesen & Pipeline-Uebersicht

CEODaniel Gotthardt
Mitarbeiter8299
HauptsitzKoblenz, DE
IPO-Jahr2012

CompuGroup Medical SE & Co. KGaA, a German-based healthcare IT firm, delivers software and IT solutions across four segments: Ambulatory, Pharmacy, Hospital, and Consumer Health. With a global presence and a focus on digital healthcare solutions, the company supports healthcare providers and consumers, holding a significant position in the healthcare information services sector.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 16. März 2026

Investmentthese

CompuGroup Medical SE & Co. KGaA presents a mixed investment thesis. The company's established presence in the healthcare IT sector and diverse product portfolio across ambulatory, pharmacy, hospital, and consumer health segments provide a stable revenue base. The company's P/E ratio is 89.71, and the profit margin is 1.5%. Growth catalysts include expanding digital health solutions and increasing demand for integrated healthcare systems. Potential risks include intense competition, evolving regulatory landscapes, and the relatively low profit margin. The company's beta of 0.82 suggests lower volatility compared to the market. The dividend yield is 0.22%.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • CompuGroup Medical operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS).
  • The company serves a global market, providing healthcare IT solutions to various healthcare providers and consumers.
  • CompuGroup Medical's gross margin stands at 83.6%, indicating strong pricing power and efficient cost management in its software and IT solutions.
  • The company's market capitalization is $1.19 billion, reflecting its significant presence in the healthcare IT sector.
  • CompuGroup Medical has a dividend yield of 0.22%, offering a modest income stream for investors.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Comprehensive product portfolio across multiple healthcare segments.
  • Established presence in the European healthcare IT market.
  • Strong gross margin of 83.6%.
  • Focus on integrated healthcare solutions.

Schwaechen

  • Relatively low profit margin of 1.5%.
  • Dependence on regulatory compliance and healthcare policies.
  • Limited presence in some emerging markets.
  • High P/E ratio of 89.71.

Katalysatoren

  • Ongoing: Increasing adoption of digital health solutions by healthcare providers and consumers.
  • Ongoing: Expansion of integrated healthcare systems and data analytics capabilities.
  • Upcoming: Potential strategic acquisitions to expand product offerings and market share.
  • Ongoing: Government initiatives promoting electronic health records and telehealth services.
  • Ongoing: Growing demand for IT security services in the healthcare sector.

Risiken

  • Potential: Intense competition from other healthcare IT providers.
  • Potential: Evolving regulatory landscape and compliance requirements.
  • Potential: Cybersecurity threats and data breaches.
  • Potential: Economic downturns affecting healthcare spending.
  • Ongoing: Currency risk associated with the ADR structure.

Wachstumschancen

  • Expansion of Digital Health Solutions: CompuGroup Medical has the opportunity to expand its digital health solutions, including consumer portals and mobile apps. The digital health market is experiencing rapid growth, driven by increasing consumer demand for convenient and accessible healthcare services. By enhancing its digital offerings, CompuGroup Medical can attract new customers and increase revenue. The global digital health market is projected to reach $660 billion by 2025, presenting a substantial growth opportunity for the company.
  • Integration of Healthcare Systems: The increasing demand for integrated healthcare systems presents a significant growth opportunity for CompuGroup Medical. Healthcare providers are seeking solutions that can seamlessly integrate data across different systems, improving efficiency and patient care. CompuGroup Medical can capitalize on this trend by developing and offering integrated solutions that connect ambulatory, pharmacy, hospital, and consumer health systems. This integration can lead to increased customer loyalty and higher revenue.
  • Geographic Expansion: CompuGroup Medical can pursue geographic expansion to tap into new markets and increase its global presence. Emerging markets, in particular, offer significant growth potential due to increasing healthcare spending and the adoption of digital health technologies. By expanding into these markets, CompuGroup Medical can diversify its revenue streams and reduce its reliance on mature markets. This expansion requires careful market analysis and strategic partnerships to navigate local regulations and cultural differences.
  • Strategic Acquisitions: CompuGroup Medical can pursue strategic acquisitions to expand its product portfolio and market share. Acquiring companies with complementary technologies or customer bases can accelerate growth and enhance the company's competitive position. Potential acquisition targets include companies specializing in telehealth, data analytics, or cybersecurity for healthcare providers. These acquisitions should be carefully evaluated to ensure they align with CompuGroup Medical's overall strategy and create synergies.
  • Data Analytics and AI: CompuGroup Medical can leverage data analytics and artificial intelligence (AI) to improve its products and services. By analyzing healthcare data, the company can identify trends, predict patient outcomes, and personalize treatment plans. AI can also be used to automate tasks, improve efficiency, and reduce costs. Investing in data analytics and AI capabilities can enhance CompuGroup Medical's competitive advantage and drive innovation in the healthcare IT sector. The market for AI in healthcare is expected to reach $34 billion by 2025.

Chancen

  • Expansion into new geographic markets.
  • Growth in the digital health solutions market.
  • Strategic acquisitions to expand product offerings.
  • Increased demand for integrated healthcare systems.

Risiken

  • Intense competition from other healthcare IT providers.
  • Evolving regulatory landscape and compliance requirements.
  • Cybersecurity threats and data breaches.
  • Economic downturns affecting healthcare spending.

Wettbewerbsvorteile

  • Established Customer Base: Long-standing relationships with a diverse customer base in the healthcare sector.
  • Integrated Solutions: Comprehensive suite of integrated software solutions across ambulatory, pharmacy, hospital, and consumer health segments.
  • Regulatory Expertise: Deep understanding of healthcare regulations and compliance requirements.
  • Data Assets: Proprietary data assets and analytics capabilities that provide valuable insights to customers.

Ueber CMPUY

CompuGroup Medical SE & Co. KGaA, founded in 1987 and headquartered in Koblenz, Germany, develops and sells software and IT solutions for the healthcare sector globally. The company operates through four key segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment offers practice management software and electronic medical records for physicians and medical centers, along with supplementary internet solutions. The PCS segment provides software applications for pharmacies, focusing on administrative and billing processes, and offers decision support for medication supply chain management. The HIS segment delivers clinical and administrative solutions for hospitals, rehabilitation centers, and medical laboratories. The CHS segment provides IT security services, data-based product offerings, software interfaces, and clinical decision-making support for healthcare providers, as well as digital healthcare platforms and mobile apps for consumers. CompuGroup Medical serves a diverse clientele, including pharmaceutical companies, health insurance companies, and individual consumers. Formerly known as CompuGroup Medical SE, the company rebranded in June 2020 to CompuGroup Medical SE & Co. KGaA, reflecting its continued evolution in the healthcare IT landscape.

Was das Unternehmen tut

  • Develops and sells software for ambulatory information systems (AIS).
  • Provides software solutions for pharmacy information systems (PCS).
  • Offers clinical and administrative solutions for hospital information systems (HIS).
  • Creates consumer and health management information systems (CHS).
  • Delivers IT security services for healthcare providers.
  • Provides data-based product offers and software interfaces for information sharing.
  • Offers clinical decision-making support and medication databases.
  • Develops digital healthcare stock, consumer portals, and mobile apps.

Geschaeftsmodell

  • Software Licensing: Generates revenue through licensing its software solutions to healthcare providers and pharmacies.
  • Subscription Services: Offers subscription-based services for ongoing access to its software and related support.
  • IT Services: Provides IT security services and data-based product offers to healthcare organizations.
  • Data Analytics: Leverages healthcare data to provide insights and analytics to improve patient outcomes and efficiency.

Branchenkontext

CompuGroup Medical operates in the rapidly evolving healthcare IT sector. The industry is driven by increasing demand for digital health solutions, electronic health records, and integrated healthcare systems. The market is competitive, with key players including BITGF (Allscripts Healthcare Solutions), BTTAY (Cerner), CSWYF (Change Healthcare), DGWPF (Teladoc Health), and DWRKF (athenahealth). These companies compete on product offerings, technological innovation, and market reach. The healthcare IT market is expected to continue growing, fueled by government initiatives promoting electronic health records and the increasing adoption of telehealth services.

Wichtige Kunden

  • Registered physicians and medical care centers.
  • Pharmacies and pharmaceutical companies.
  • Acute care hospitals and rehabilitation centers.
  • Health insurance companies.
  • Consumers seeking digital health solutions.
KI-Zuversicht: 71% Aktualisiert: 16. März 2026

Finanzdaten

Chart & Info

CompuGroup Medical SE & Co. KGaA (CMPUY) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Keine aktuellen Nachrichten fuer CMPUY verfuegbar.

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer CMPUY.

Kursziele

Wall-Street-Kurszielanalyse fuer CMPUY.

MoonshotScore

48/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von CMPUY auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Klassifizierung

Sektor Healthcare Branche Medical - Healthcare Information Services

Fuehrung: Daniel Gotthardt

Unknown

Information on Daniel Gotthardt's background is not available in the provided data. Therefore, a detailed career history, education, and previous roles cannot be provided. His experience prior to managing 8299 employees at CompuGroup Medical SE & Co. KGaA is Unknown.

Erfolgsbilanz: Due to the limited information available, Daniel Gotthardt's key achievements, strategic decisions, and company milestones under his leadership cannot be detailed. His specific contributions to CompuGroup Medical SE & Co. KGaA's performance are Unknown.

CompuGroup Medical SE & Co. KGaA ADR-Informationen Nicht gesponsert

An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. CMPUY is an ADR representing shares of CompuGroup Medical SE & Co. KGaA, a German company. This allows U.S. investors to invest in the company without directly dealing with foreign exchanges.

  • Heimatmarkt-Ticker: Frankfurt Stock Exchange, Germany
  • ADR-Stufe: 1
  • ADR-Verhaeltnis: 1:1
  • Heimatmarkt-Ticker: CMPU
Waehrungsrisiko: As an ADR, CMPUY is subject to currency risk. The value of the ADR can be affected by fluctuations in the exchange rate between the U.S. dollar and the Euro. If the Euro weakens against the dollar, the value of CMPUY in dollar terms may decrease, impacting returns for U.S. investors.
Steuerliche Auswirkungen: Dividends paid on CMPUY are subject to foreign dividend withholding tax in Germany. The standard withholding tax rate is Unknown, but this may be reduced by tax treaties between the U.S. and Germany. U.S. investors may be able to claim a foreign tax credit on their U.S. tax return for the amount of foreign tax withheld.
Handelszeiten: Trading hours for CMPUY in the U.S. market may differ from the trading hours of the home market (Frankfurt Stock Exchange). The Frankfurt Stock Exchange typically operates from 9:00 AM to 5:30 PM Central European Time (CET), while U.S. markets operate from 9:30 AM to 4:00 PM Eastern Time (ET). This difference in trading hours can affect the timing of price movements and trading opportunities.

CMPUY OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that CompuGroup Medical SE & Co. KGaA has limited regulatory requirements and reporting standards compared to companies listed on major exchanges like the NYSE or NASDAQ. Companies on this tier may not be required to file regular financial reports with the SEC, leading to less transparency for investors. Investing in OTC Other stocks carries higher risks due to the limited information available.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: Liquidity for CMPUY on the OTC market is likely to be limited. OTC stocks generally have lower trading volumes and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more difficult to buy or sell shares quickly and at a favorable price. Investors should be prepared for potential price volatility and illiquidity when trading CMPUY.
OTC-Risikofaktoren:
  • Limited Transparency: OTC stocks often have limited financial disclosure, making it difficult to assess their true value and financial health.
  • Low Liquidity: Trading volumes can be thin, leading to wider bid-ask spreads and difficulty in executing large trades.
  • Price Volatility: OTC stocks can be more susceptible to price manipulation and volatility due to lower trading volumes.
  • Regulatory Risks: OTC companies may not be subject to the same level of regulatory scrutiny as exchange-listed companies.
  • Information Asymmetry: Limited access to information can create an uneven playing field for investors.
Sorgfaltspruefung-Checkliste:
  • Verify the company's registration and legal status.
  • Review available financial statements and disclosures.
  • Assess the company's business model and competitive landscape.
  • Evaluate the management team and their track record.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before investing.
  • Monitor the company's news and announcements for any updates.
Legitimitaetssignale:
  • Established Business Operations: CompuGroup Medical SE & Co. KGaA has been in operation since 1987, indicating a long-standing presence in the healthcare IT sector.
  • Global Presence: The company operates worldwide, serving various healthcare providers and consumers.
  • Diverse Product Portfolio: CompuGroup Medical offers a comprehensive suite of software and IT solutions across multiple healthcare segments.
  • ADR Listing: The existence of an ADR, even at Level I, suggests some level of compliance and oversight.

CMPUY Healthcare Aktien-FAQ

What are the key factors to evaluate for CMPUY?

CompuGroup Medical SE & Co. KGaA (CMPUY) currently holds an AI score of 48/100, indicating low score. Key strength: Comprehensive product portfolio across multiple healthcare segments.. Primary risk to monitor: Potential: Intense competition from other healthcare IT providers.. This is not financial advice.

How frequently does CMPUY data refresh on this page?

CMPUY prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven CMPUY's recent stock price performance?

Recent price movement in CompuGroup Medical SE & Co. KGaA (CMPUY) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Comprehensive product portfolio across multiple healthcare segments.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider CMPUY overvalued or undervalued right now?

Determining whether CompuGroup Medical SE & Co. KGaA (CMPUY) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying CMPUY?

Before investing in CompuGroup Medical SE & Co. KGaA (CMPUY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding CMPUY to a portfolio?

Potential reasons to consider CompuGroup Medical SE & Co. KGaA (CMPUY) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Comprehensive product portfolio across multiple healthcare segments.. Additionally: Established presence in the European healthcare IT market.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of CMPUY?

Yes, most major brokerages offer fractional shares of CompuGroup Medical SE & Co. KGaA (CMPUY) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track CMPUY's earnings and financial reports?

CompuGroup Medical SE & Co. KGaA (CMPUY) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for CMPUY earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Information is based on available data as of 2026-03-16.
  • AI analysis pending for CMPUY, which may provide further insights.
  • OTC market data may be limited and less reliable than exchange-listed data.
Datenquellen

Popular Stocks